# Orgenesis Stock Volatility

ORGS | - USA Stock | ## USD 4.78 0.13 2.65% |

We consider Orgenesis relatively risky. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of 0.0304, which implies the firm had 0.0304% of return per unit of risk over the last 3 months. Our standpoint towards forecasting the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Orgenesis, which you can use to evaluate the future volatility of the company. Please check Orgenesis Risk Adjusted Performance of 0.0113, semi deviation of 4.08, and Coefficient Of Variation of 28158.17 to confirm if the risk estimate we provide is consistent with the expected return of 0.17%.

Orgenesis Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Orgenesis daily returns, and it is calculated using variance and standard deviation. We also use Orgenesis's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Orgenesis volatility.

### 90 Days Market Risk

### Chance of Distress

### 90 Days Economic Sensitivity

## Orgenesis Market Sensitivity And Downside Risk

Orgenesis' beta coefficient measures the volatility of Orgenesis stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Orgenesis stock's returns against your selected market. In other words, Orgenesis's beta of 2.87 provides an investor with an approximation of how much risk Orgenesis stock can potentially add to one of your existing portfolios.

Let's try to break down what Orgenesis's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Orgenesis will likely underperform. 3 Months Beta |Analyze Orgenesis Demand TrendCheck current 90 days Orgenesis correlation with market (DOW)## Orgenesis Beta |

## Standard Deviation | 5.56 |

It is essential to understand the difference between upside risk (as represented by Orgenesis's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Orgenesis stock's daily returns or price. Since the actual investment returns on holding a position in Orgenesis stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Orgenesis.

## Orgenesis Stock Volatility Analysis

Transformation |

The output start index for this execution was zero with a total number of output elements of sixty-one. Orgenesis Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

## Orgenesis Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 2.8656 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Orgenesis will likely underperform.

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Orgenesis or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Orgenesis stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Orgenesis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.

The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Orgenesis is significantly underperforming DOW. Predicted Return Density |

Returns |

## Orgenesis Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Orgenesis or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Orgenesis stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Orgenesis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.

Given the investment horizon of 90 days the coefficient of variation of Orgenesis is 3291.56. The daily returns are distributed with a variance of 30.9 and standard deviation of 5.56. The mean deviation of Orgenesis is currently at 3.8. For similar time horizon, the selected benchmark (DOW) has volatility of 0.73α | Alpha over DOW | -0.1 | |

β | Beta against DOW | 2.87 | |

σ | Overall volatility | 5.56 | |

Ir | Information ratio | -0.0052 |

## Orgenesis Stock Return Volatility

Orgenesis historical daily return volatility represents how much Orgenesis stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The enterprise inherits 5.559% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 0.749% risk (volatility on return distribution) over the 90 days horizon.

Performance (%) |

Timeline |

## About Orgenesis Volatility

Volatility is a rate at which the price of Orgenesis or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Orgenesis may increase or decrease. In other words, similar to Orgenesis's beta indicator, it measures the risk of Orgenesis and helps estimate the fluctuations that may happen in a short period of time. So if prices of Orgenesis fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.

Please read more on our technical analysis page.Orgenesis Inc., a biotech company, focusing on cell and gene therapies . The company was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 111 people.## Orgenesis Investment Opportunity

Orgenesis has a volatility of 5.56 and is 7.41 times more volatile than DOW.

**47**of all equities and portfolios are less risky than Orgenesis. Compared to the overall equity markets, volatility of historical daily returns of Orgenesis is lower than**47 ()**of all global equities and portfolios over the last 90 days. Use Orgenesis to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Orgenesis to be traded at $4.59 in 90 days. . Let's try to break down what Orgenesis's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Orgenesis will likely underperform.### Weak diversification

The correlation between Orgenesis and DJI is

**Weak diversification**for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Orgenesis and DJI in the same portfolio assuming nothing else is changed.## Orgenesis Additional Risk Indicators

The analysis of Orgenesis' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Orgenesis' investment and either accepting that risk or mitigating it. Along with some common measures of Orgenesis stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.

Risk Adjusted Performance | 0.0113 | |||

Market Risk Adjusted Performance | 0.0132 | |||

Mean Deviation | 3.69 | |||

Semi Deviation | 4.08 | |||

Downside Deviation | 4.14 | |||

Coefficient Of Variation | 28158.17 | |||

Standard Deviation | 5.42 |

Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

## Orgenesis Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.

The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Orgenesis as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Orgenesis' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Orgenesis' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Orgenesis.

Please check Your Equity Center. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

## Complementary Tools for Orgenesis Stock analysis

When running Orgenesis price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.

Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities | Go | |

Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing | Go | |

Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets | Go | |

Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum | Go | |

Content SyndicationQuickly integrate customizable finance content to your own investment portal | Go | |

Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities | Go | |

Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation | Go | |

Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios | Go |

The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine Orgenesis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.